Maven Bio
New accelerator entry · 2023-07-11 · the record
In their words
Maven Bio is a live intelligence platform for biopharma teams. It continuously monitors clinical, regulatory, company, and deal developments, identifies what matters to each team's priorities, and delivers signals and updates to keep key documents current. Its monitoring agent can apply edits automatically, with sources attached and the option to roll back changes. Maven runs thousands of monitors across company and individual product websites, trade press, health technology assessment bodies, and patient advocacy groups worldwide. Teams use that intelligence to maintain competitive views, asset screens, and recurring briefs, in Maven or through connected AI assistants and custom workflows.
What the record says
- One of 642 companies held here in B2B.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Maven Bio
- Source Check — verify what Maven Bio states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Maven Bio for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Maven BioYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Maven Bio: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.